Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 16.
Article
Ali, S;
Wall, IB;
Mason, C;
Pelling, AE;
Veraitch, FS;
(2015)
The effect of Young's modulus on the neuronal differentiation of mouse embryonic stem cells.
Acta Biomaterialia
, 25
pp. 253-267.
10.1016/j.actbio.2015.07.008.
|
 |
|
Caplan, AI;
Mason, C;
Reeve, B;
(2017)
The 3Rs of Cell Therapy.
Stem Cells Translational Medicine
, 6
(1)
pp. 17-21.
10.5966/sctm.2016-0180.
|
|
|
Cossu, G;
Birchall, M;
Brown, T;
De Coppi, P;
Culme-Seymour, E;
Gibbon, S;
Hitchcock, J;
... Wilson, JGS; + view all
(2018)
Lancet Commission: Stem Cells and Regenerative Medicine.
The Lancet
, 391
(10123)
pp. 883-910.
10.1016/S0140-6736(17)31366-1.
|
|
Dahl, Maria;
Smith, Emma MK;
Warsi, Sarah;
Rothe, Michael;
Ferraz, Maria J;
Aerts, Johannes MFG;
Golipour, Azadeh;
... Karlsson, Stefan; + view all
(2021)
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector.
Molecular Therapy - Methods & Clinical Development
, 20
pp. 312-323.
10.1016/j.omtm.2020.11.018.
|
|
Detela, G;
Bain, OW;
Kim, H-W;
Williams, DJ;
Mason, C;
Mathur, A;
Wall, IB;
(2018)
Donor Variability in Growth Kinetics of Healthy hMSCs Using Manual Processing: Considerations for Manufacture of Cell Therapies.
Biotechnology Journal
, 13
(2)
, Article 1700085. 10.1002/biot.201700085.
|
|
|
Dogan, Y;
Barese, CN;
Schindler, JW;
Yoon, JK;
Unnisa, Z;
Guda, S;
Jacobs, ME;
... van Til, NP; + view all
(2022)
Screening chimeric GAA variants in preclinicalstudy results in hematopoietic stem cell genetherapy candidate vectors for Pompe disease.
Molecular Therapy: Methods & Clinical Development
, 27
pp. 464-487.
10.1016/j.omtm.2022.10.017.
|
|
Georgiou, M;
Reis, JND;
Wood, R;
Esteban, PP;
Roberton, V;
Mason, C;
Li, D;
... Wall, I; + view all
(2018)
Bioprocessing strategies to enhance the challenging isolation of neuro-regenerative cells from olfactory mucosa.
Scientific Reports
, 8
, Article 14440. 10.1038/s41598-018-32748-w.
|
|
|
Hamilton, NJ;
Kanani, M;
Roebuck, DJ;
Hewitt, RJ;
Cetto, R;
Culme-Seymour, EJ;
Toll, E;
... Birchall, MA; + view all
(2015)
Tissue-engineered tracheal replacement in a child: a 4-year follow-up study.
Am J Transplant
, 15
(10)
pp. 2750-2757.
10.1111/ajt.13318.
|
|
|
Hussain, W;
Moens, N;
Veraitch, FS;
Hernandez, D;
Mason, C;
Lye, GJ;
(2013)
Reproducible culture and differentiation of mouse embryonic stem cells using an automated microwell platform.
Biochem Eng J
, 77
(100)
246 - 257.
10.1016/j.bej.2013.05.008.
|
 |
|
Mondragon-Teran, P;
Tostoes, R;
Mason, C;
Lye, GJ;
Veraitch, FS;
(2013)
Oxygen-controlled automated neural differentiation of mouse embryonic stem cells.
Regen Med
, 8
(2)
171 - 182.
10.2217/rme.13.12.
|
|
|
Plews, JR;
Li, JL;
Jones, M;
Moore, HD;
Mason, C;
Andrews, PW;
Na, J;
(2010)
Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach.
PLOS ONE
, 5
(12)
, Article e14397. 10.1371/journal.pone.0014397.
|
|
|
Sharma, V;
Kohli, N;
Moulding, D;
Afolabi, H;
Hook, L;
Mason, C;
Garcia-Gareta, E;
(2017)
Design of a Novel Two-Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores.
Macromolecular Bioscience
, 17
(11)
, Article 1700185. 10.1002/mabi.201700185.
|
|
|
Smith, DM;
Culme-Seymour, EJ;
Mason, C;
(2018)
Evolving Industry Partnerships and Investments in Cell and Gene Therapies.
Cell Stem Cell
, 22
(5)
pp. 623-626.
10.1016/j.stem.2018.03.004.
|
|
|
Tostoes, R;
Dodgson, J;
Weil, B;
Gerontas, S;
Mason, C;
Veraitch, FS;
(2017)
A novel filtration system for point of care washing of cellular therapy products.
Journal of Tissue Engineering and Regenerative Medicine
, 11
(11)
pp. 3157-3167.
10.1002/term.2225.
|
|
Unnisa, Zeenath;
Yoon, John K;
Schindler, Jeffrey W;
Mason, Chris;
van Til, Niek P;
(2022)
Gene Therapy Developments for Pompe Disease.
Biomedicines
, 10
(2)
, Article 302. 10.3390/biomedicines10020302.
|
|
|
Yoon, John K;
Schindler, Jeffrey W;
Loperfido, Mariana;
Baricordi, Cristina;
DeAndrade, Mark P;
Jacobs, Mary E;
Treleaven, Christopher;
... van Til, Niek P; + view all
(2024)
Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.
Molecular Therapy
, 32
(11)
pp. 3847-3864.
10.1016/j.ymthe.2024.09.024.
|
